Project Grant R21HL181701
- This Project Grant award of $229,245 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will support research at the University of North Carolina at Chapel Hill to: Develop a multi-item demographic variable survey module to better measure demographic characteristics and self-identity across different subgroups, addressing gaps in existing data collection methods. Evaluate the association between demographic variables and cardiovascular risk factors....
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,559,542 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Medical College of Wisconsin, Inc. (MCW) to study the cardiometabolic impact of gender-affirming hormone therapy (GAHT) in transgender and gender diverse (TGD) young adults. The study aims to better define the vascular and cardiometabolic effects of modern GAHT in this population, as current knowledge relies on limited data. The 14-month...
- This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Federal Grant Program for Cardiovascular Diseases Research (CFDA 93.837), provides $123,104 to Emory University to conduct research on factors contributing to cardiovascular disease (CVD) comorbidities in persons living with HIV (PWH). The key objectives are to: 1) assess relationships between the metabolome, lipidome, HIV reservoir, and subclinical CVD, analyzing differences by sex; and 2) determine...
- This $275,196 federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research at the University of Chicago investigating the impact of adolescent reproductive health factors on the risk of cardiometabolic disease in young adult women. The project aims to analyze longitudinal data from the Pittsburgh Girls Study to examine associations between adolescent pubertal development, sexual health, and pregnancy history with...
- The National Heart, Lung, and Blood Institute awarded a $156,486 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Denver. The 5-year grant, running from July 2, 2025 to January 5, 2027, will support research examining the association between discrimination reported during pregnancy and cardiovascular disease risk in mothers 3-4 years postpartum. The study will use a prospective longitudinal design with a population of at least 200...
- The National Heart, Lung, and Blood Institute awarded a $133,125 project grant to Northwestern University under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the relationship between early life social determinants of health, epigenetic changes, and young adult blood pressure levels. The overarching goal is to identify potential epigenetic mechanisms that mediate the association between social determinants and the development of hypertension, a key risk factor for...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $156,486 to Emory University to evaluate how immigration status contributes to disparities in cardiometabolic health and epigenetic aging among Hispanic/Latino populations in the U.S. The research leverages data from the California Health Interview Survey and the Hispanic Community Health Study/Study of Latinos to investigate the associations between...
- This Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research, provides $815,229 to The University of Texas Southwestern Medical Center to conduct advanced research on cardiovascular disease susceptibility and resilience in Black Americans. The key objectives are to: 1) Identify proteins and protein networks associated with clinical and subclinical cardiac dysfunction, 2) Pinpoint proteins and networks linked to...
- This Project Grant award, totaling $136,646, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to Duke University. The funding will support a 5-year observational study to assess sex differences in physical activity (PA) participation and maintenance among individuals enrolled in cardiac rehabilitation (CR) programs. The key objectives are to: 1) identify sex differences in PA participation during and after...
- This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), will fund research to investigate place-based factors contributing to sleep health disparities in the United States. The $177,385 award to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System, will: 1) Estimate sleep health measures and environmental circadian misalignment across different populations and geographies; 2) Examine...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund a study to assess disparities in cardiovascular health outcomes between sexual minority (e.g. lesbian, gay, bisexual) and straight adults. The $259,729 award, spanning September 2025 to June 2027, will enable Northwestern University to: 1) Evaluate differences in the prevalence and incidence of cardiometabolic conditions and cardiovascular disease by sexual orientation, and 2) Examine how social determinants like education, income, and discrimination may contribute to these disparities. The study will leverage Kaiser Permanente's electronic health records and survey data to conduct the analyses. Results will help guide the development of targeted health programs to address cardiovascular health inequities faced by sexual minority populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $259.7k | 9/19/25 |